antovic.jpg Jovan P Antovic
Columnista Experto de SIIC


Medical Advisor. Specialization field: Hematology, Novo Nordisk ROSEE, Ljubljana, Eslovenia
INHIBIDOR DE LA FIBRINOLISIS ACTIVADO POR TROMBINA (TAFI): NEXO ENTRE LA COAGULACION Y LA FIBRINOLISIS
Columnista Experto de SIIC Jovan P Antovic en colaboración con


Fecha de aprobación: 6 de septiembre, 2005
Primera edición en siicsalud: 10 de abril, 2006
Sección Artículos originales, subsección Expertos de Iberoamérica,
página /des/expertocompleto.php/76185  
Especialidad principal: Especialidad principalBioquímica

Especialidades relacionadas:
Diagnóstico por Laboratorio,Hematología,Medicina Interna,

  • Antovic JP, Hannerz J, Nekludov M, Blombäck M. TAFI antigen could not be detected in cerebrospinal fluid, Thromb Haemost 93:178-9, 2005

  • Antovic JP, Schulman S, An SSA, Greenfield R, Blömback M. Does enzyme other than thrombin contribute to unexpected changes in the levels of the different forms of thrombin activatable fibrinolysis inhibitor (TAFI) in patients with hemophilia A, B and Von Willebrand disease, Scand J Lab Clin Invest 64:745-52, 2004

  • Antovic JP, Antovic A, Sten-Linder M, Wramsby M, Blombäck M. Overall hemostatic potential (OHP) assay – a possible tool for determination of prothtrombotic pattern in FXII deficiency, J Thromb Haemost 2:2058-60, 2004

  • Antovic JP. Thrombin activatable fibrinolysis inhibitor (TAFI) a link between coagulation and fibrinolysis (review), Clin Lab 49:475-86, 2003

  • Antovic JP, Antovic A. Does recombinant factor VIIa apart from overall hemostasis regulate TAFI dependent fibrinolysis– in vitro analysis using overall hemostasis potential (OHP) assay, Thromb Haemost 90:620-8, 2003

  • Antovic JP, Yngen M, Östenson CG, Antovic A, Wallen NH, Jorneskog G, Blombäck M. Thrombin activatable fibrinolysis inhibitor (TAFI) and hemostatic changes in patients with type I diabetes mellitus with and without microvascular complications, Blood Coag Fibrinolys 14:551-6, 2003


  • Jovan P Antovic

    ua40317